Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Fastnet Equity closing in on potential pharma deal

Fastnet Equity has requested its shares to be suspended as it closes in on a potential deal to buy Amryt Pharmaceuticals DAC.
Fastnet Equity closing in on potential pharma deal
The firm said it was in very advanced discussions with Amryt Pharmaceuticals DAC

Fastnet Equity (LON:FAST) has requested its shares to be suspended as it closes in on a potential deal to buy  Amryt Pharmaceuticals DAC.

As reported last year Fastnet drew a line under its oil and gas business and started to look for healthcare businesses to acquire.

The company says it's now in very advanced discussions with Amryt Pharmaceuticals DAC.

If this acquisition proceeds, which would constitute a reverse takeover, the enlarged group will become a late stage, specialty biopharmaceutical, it said today.

A further announcement will be made in due course.

Giles_55af4ddca6481.jpg
Why Invest In Amryt Pharmaceuticals? Read More Here

Register here to be notified of future AMYT Company articles
View full AMYT profile

Amryt Pharmaceuticals Timeline

Newswire
January 27 2015

Related Articles

cells_56ab78cfbeec5.jpg
January 29 2016
A return to Nasdaq and ongoing commercial success promises to address a significant disconnect in the valuation of Pressure Bioscience...
shutterstock_184785974.jpg
April 28 2016
Last year's acquisition of Kinesis Pharma meant that it could now offer a one-stop shop for its pharmaceuticals clients and expand its client base.
Harley Street London street sign
Fri
The cancer treatment specialist has received funding to bring its breakthrough therapy to London.

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.